Ketamine Research for Treatment-Resistant Depression (Early Work Through Current State)
Neuro Pathways: A Cleveland Clinic Podcast for Medical Professionals - A podcast by Cleveland Clinic Neurological Institute
Roughly one in 10 Americans takes an antidepressant to aid in the debilitating symptoms of clinical depression, but for some medications donβt work. In this episode, Amit Anand, MD, discusses the evolving therapies for treatment-resistant depression, including ketamine and esketamine. For information about claiming CE credits, go to clevelandclinic.org/neuropodcast and click on the episode.
